ARMP - Armata Pharmaceuticals, Inc.
8.37
-0.980 -11.708%
Share volume: 27,065
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.35
-0.98
-0.10%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-13-2024 | 11-13-2024 | 03-21-2025 | 05-14-2025 | 08-12-2025 | 11-12-2025 | 03-25-2026 | |
| Assets | |||||||||
| Total Assets | 120.356 M | 108.313 M | 98.237 M | 86.437 M | 87.250 M | 80.790 M | 89.516 M | 76.882 M | |
| Current Assets | 41.717 M | 30.903 M | 22.389 M | 11.308 M | 13.166 M | 7.520 M | 16.930 M | 10.668 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.714 M | 1.242 M | 2.219 M | 744.000 K | 238.000 K | 2.168 M | 759.000 K | 472.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 37.860 M | 26.405 M | 17.141 M | 9.291 M | 11.688 M | 4.328 M | 14.756 M | 8.688 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 12.700 M | 13.474 M | 13.616 M | 13.241 M | 12.883 M | 12.657 M | 12.560 M | 12.194 M | |
| Other Assets | 65.939 M | 63.936 M | 62.232 M | 61.888 M | 61.201 M | 60.613 M | 60.026 M | 54.020 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 120.356 M | 108.313 M | 98.237 M | 86.437 M | 87.250 M | 80.790 M | 89.516 M | 76.882 M | |
| Total liabilities | 176.866 M | 154.414 M | 149.210 M | 134.456 M | 141.033 M | 150.293 M | 185.104 M | 295.478 M | |
| Total current liabilities | 110.045 M | 123.181 M | 118.204 M | 48.249 M | 110.540 M | 120.085 M | 139.950 M | 8.947 M | |
| Accounts Payable | 4.610 M | 3.851 M | 3.714 M | 2.055 M | 1.614 M | 1.540 M | 1.999 M | 1.705 M | |
| Other liabilities | 28.376 M | 28.156 M | 27.929 M | 27.694 M | 27.416 M | 27.131 M | 26.837 M | 26.533 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 35.368 M | 0.000 | 0.000 | 55.436 M | 0.000 | 0.000 | 15.240 M | 256.921 M | |
| Other liabilities | 28.376 M | 28.156 M | 27.929 M | 27.694 M | 27.416 M | 27.131 M | 26.837 M | 26.533 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -56.510 M | -46.101 M | -50.973 M | -48.019 M | -53.783 M | -69.503 M | -95.588 M | -218.596 M | |
| Common stock | 277.330 M | 278.753 M | 279.362 M | 279.716 M | 280.483 M | 281.058 M | 281.648 M | 282.938 M | |
| Retained earnings | -333.840 M | -324.854 M | -330.335 M | -327.735 M | -334.266 M | -350.561 M | -377.236 M | -501.534 M |